← Back to Screener
Heartbeam, Inc. Common Stock (BEAT)
Price$0.84
Momentum ScoreD
Favorite Metrics
Price vs S&P 500 (26W)38.60%
Price vs S&P 500 (4W)0.52%
VGM Score39.91
Market Capitalization$46.56M
All Metrics
Book Value / Share (Quarterly)$0.02
P/TBV (Annual)15.20x
Indicated Dividend (Annual)$0.00
Cash Flow / Share (Quarterly)$-0.34
Price vs S&P 500 (YTD)-73.29%
EPS (TTM)$-0.56
10-Day Avg Trading Volume0.60M
EPS Excl Extra (TTM)$-0.56
EPS (Annual)$-0.62
ROI (Annual)-807.34%
Cash / Share (Quarterly)$0.05
ROA (Last FY)-359.66%
EBITD / Share (TTM)$-0.56
ROE (5Y Avg)-530.98%
Cash Flow / Share (Annual)$-0.36
P/B Ratio73.33x
P/B Ratio (Quarterly)79.02x
Net Income / Employee (Annual)$-1,313,400
Net Interest Coverage (TTM)-1.04x
ROA (TTM)-434.40%
EPS Incl Extra (Annual)$-0.62
Current Ratio (Annual)1.45x
Quick Ratio (Quarterly)0.62x
3-Month Avg Trading Volume1.22M
52-Week Price Return-46.10%
Revenue / Employee (TTM)$0
Tangible BV / Share (Quarterly)$0.71
52-Week High$4.00
EPS Excl Extra (Annual)$-0.62
26-Week Price Return49.99%
Quick Ratio (Annual)1.35x
13-Week Price Return-40.82%
Total Debt / Equity (Annual)0.00x
Current Ratio (Quarterly)0.74x
Enterprise Value$44.53M
Revenue / Employee (Annual)$0
Cash / Share (Annual)$0.11
3-Month Return Std Dev89.95%
Net Income / Employee (TTM)$-1,264,400
ROE (Last FY)-807.34%
Net Interest Coverage (Annual)-1.06x
EPS Basic Excl Extra (Annual)$-0.62
Total Debt / Equity (Quarterly)0.00x
EPS Incl Extra (TTM)$-0.56
ROI (TTM)-1034.04%
Revenue / Share (Annual)$0.00
Tangible BV / Share (Annual)$0.30
Price vs S&P 500 (52W)-73.14%
Year-to-Date Return-62.27%
5-Day Price Return3.49%
EPS Normalized (Annual)$-0.62
ROA (5Y Avg)-278.24%
Month-to-Date Return3.49%
Cash Flow / Share (TTM)$-0.24
EBITD / Share (Annual)$-0.63
ROI (5Y Avg)-530.98%
EPS Basic Excl Extra (TTM)$-0.56
P/TBV (Quarterly)1.94x
P/B Ratio (Annual)31.76x
Book Value / Share (Annual)$0.06
Price vs S&P 500 (13W)-51.32%
Beta-0.69x
Revenue / Share (TTM)$0.00
ROE (TTM)-1034.04%
52-Week Low$0.54
mGradeD
vgmGradeD
Show chart for
Earnings Surprise History
Q1 26-0.12est. -0.14
Analyst Recommendations
Mar 2026
Apr 2026
May 2026
Jun 2026
4.10
4.09
4.00
4.11
Industry Peers — Surgical & Medical Instruments(138)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
BEATHeartbeam, Inc. Common Stock | — | — | D | $0.84 |
| SYKStryker Corporation | C | C | C | $305.66 |
| MMM3M Company | C | F | C | $153.76 |
| BSXBoston Scientific Corp. | C | B | D | $48.55 |
| MDLNMedline Inc. Class A common stock | C | D | D | $33.61 |
| BDXBecton, Dickinson and Co. | B | C | C | $151.16 |
| RMDResMed Inc. | C | B | C | $196.04 |
| DXCMDexCom, Inc. | C | B | C | $72.86 |
| WSTWest Pharmaceutical Services, Inc. | D | C | B | $314.50 |
| SOLVSolventum Corporation | C | D | B | $81.01 |
| PENPenumbra, Inc. | F | C | B | $320.53 |
About
HeartBeam develops ambulatory ECG solutions using proprietary Vector Electrocardiography (VECG) technology to enable cardiac disease detection and monitoring outside traditional healthcare settings. The company's validated platform provides higher-resolution remote monitoring capabilities for telehealth applications. HeartBeam is pursuing FDA clearance for its initial telehealth products.